triamcinolone has been researched along with Myopia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, C; Chen, F; Wang, H; Wang, N; Wei, Y; Yang, X; Zu, Z | 1 |
Engelmann, K; Fauser, S; Joussen, AM; Kirchhof, B; Krohne, TU; Lappas, A | 1 |
Fujikado, T; Gomi, F; Harino, S; Ikuno, Y; Kamei, M; Ohji, M; Sayanagi, K; Tano, Y | 1 |
Becquet, F; Ducournau, D; Le Rouic, JF | 1 |
Chen, B; Chen, Z; Fang, X; Liu, J; Ni, H; Weng, Y; Wu, P; Yao, K; Zheng, X | 1 |
1 review(s) available for triamcinolone and Myopia
Article | Year |
---|---|
[Pathogenesis of choroidal neovascularization. Old concepts, new questions].
Topics: Age Factors; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Cells, Cultured; Choroidal Neovascularization; Choroiditis; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Disease Models, Animal; Endothelial Growth Factors; Eye Injuries; Haplorhini; Humans; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Laser Therapy; Lymphokines; Macula Lutea; Macular Degeneration; Mice; Mice, Transgenic; Myopia; Photochemotherapy; Pigment Epithelium of Eye; Rats; Retinal Neovascularization; Risk Factors; Triamcinolone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
1 trial(s) available for triamcinolone and Myopia
Article | Year |
---|---|
Efficacy of vitrectomy with triamcinolone assistance versus internal limiting membrane peeling for highly myopic macular hole retinal detachment.
Topics: Aged; Case-Control Studies; Chemotherapy, Adjuvant; Combined Modality Therapy; Epiretinal Membrane; Female; Glucocorticoids; Humans; Logistic Models; Male; Middle Aged; Myopia; Retinal Detachment; Retinal Perforations; Triamcinolone; Vitrectomy | 2013 |
3 other study(ies) available for triamcinolone and Myopia
Article | Year |
---|---|
Vitrectomy and internal limiting membrane peeling for myopic foveoschisis.
Topics: Basement Membrane; Coloring Agents; Enzyme Inhibitors; Female; Fluorocarbons; Fovea Centralis; Humans; Indocyanine Green; Male; Middle Aged; Myopia; Ophthalmoscopy; Pilot Projects; Retinal Detachment; Retinoschisis; Staining and Labeling; Tomography, Optical Coherence; Triamcinolone; Visual Acuity; Visual Field Tests; Vitrectomy | 2004 |
[Triamcinolone-assisted vitrectomy in the treatment of recurrent retinal detachment due to myopic macular hole].
Topics: Aged; Combined Modality Therapy; Female; Humans; Middle Aged; Myopia; Recurrence; Retinal Detachment; Retinal Perforations; Treatment Failure; Triamcinolone; Vitrectomy | 2006 |
Anatomical and visual outcome after vitrectomy with triamcinolone acedonide-assisted epiretinal membrane removal in highly myopic eyes with retinal detachment due to macular hole.
Topics: Adult; Aged; Epiretinal Membrane; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Microscopy, Electron; Middle Aged; Myopia; Retinal Detachment; Retinal Perforations; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitrectomy | 2009 |